EFEMP1 Overexpression Contributes to Neovascularization in Age-Related Macular Degeneration
Conclusion: Our findings demonstrate EFEMP1 as a novel biomarker for CNV in AMD, providing a new target for the development of wet AMD-directed pharmaceuticals and diagnostics.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Blindness | Cataracts | Drugs & Pharmacology | Eyes | Genetics | Opthalmology | Study | Vitamin A